Carbidopa; Entacapone; Levodopa Patents

Given below is the list of patents protecting Carbidopa; Entacapone; Levodopa, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Carbidopa; Entacapone; Levodopa's patents.

Latest Legal Activities on Carbidopa; Entacapone; Levodopa's Patents

Given below is the list recent legal activities going on the following patents of Carbidopa; Entacapone; Levodopa.

Activity	Date	Patent Number
Critical Events This Week
Recordation of Patent Grant Mailed Critical	28 Sep, 2004	US6797732
Patent Issue Date Used in PTA Calculation Critical	28 Sep, 2004	US6797732
Issue Notification Mailed Critical	09 Sep, 2004	US6797732
Receipt into Pubs	03 Sep, 2004	US6797732
Application Is Considered Ready for Issue Critical	01 Sep, 2004	US6797732
Dispatch to FDC	01 Sep, 2004	US6797732
Issue Fee Payment Received Critical	18 Aug, 2004	US6797732
Issue Fee Payment Verified Critical	18 Aug, 2004	US6797732
Receipt into Pubs	17 Aug, 2004	US6797732
Receipt into Pubs	07 Jun, 2004	US6797732